biosig_rgb.png
BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare
27 juin 2023 08h30 HE | BioSig Technologies, Inc.
Westport, CT, June 27, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
FBI LOGO TM.png
Foot Orthotic Insoles Market Size to Surpass USD 6.26 Billion in 2030, exhibiting a CAGR of 6.8%
22 juin 2023 07h34 HE | Fortune Business Insights
Pune, India, June 22, 2023 (GLOBE NEWSWIRE) -- The global foot orthotic insoles market size was USD 3.62 billion in 2022. The market is anticipated to expand from USD 3.96 billion in 2023 to USD...
CytoSorbents New Logo - 2021.png
CytoSorbents Announces Independent Data Safety and Monitoring Board Recommends Completion of the Pivotal STAR-T Trial Without Modifications Following Second Scheduled Safety Review
15 juin 2023 07h00 HE | CytoSorbents
PRINCETON, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
biosig_rgb.png
BioSig to Highlight New Data from the PURE EP™ Platform at Heart Rhythm 2023
03 mai 2023 09h00 HE | BioSig Technologies, Inc.
Westport, CT, May 03, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
CytoSorbents New Logo - 2021.png
CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled
20 avr. 2023 07h00 HE | CytoSorbents
PRINCETON, N.J., April 20, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
biosig_rgb.png
BioSig Announces New Advisory Board Member Edwin Wang
27 mars 2023 08h38 HE | BioSig Technologies, Inc.
Westport, CT, March 27, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
biosig_rgb.png
BioSig Announces New Advisory Board Member Lorraine Spurge
24 mars 2023 08h30 HE | BioSig Technologies, Inc.
Westport, CT, March 24, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
biosig_rgb.png
BioSig Confirms No Exposure to Silicon Valley Bank
13 mars 2023 07h30 HE | BioSig Technologies, Inc.
Westport, CT, March 13, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
biosig_rgb.png
BioSig Regains Compliance With All Nasdaq Listing Standards
22 févr. 2023 07h30 HE | BioSig Technologies, Inc.
Westport, CT, Feb. 22, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), an advanced digital signal processing technology company delivering...
biosig_rgb.png
BioSig Awarded US Patent Claims for its Universal Notch Filter Technology
17 févr. 2023 07h30 HE | BioSig Technologies, Inc.
Westport, CT, Feb. 17, 2023 (GLOBE NEWSWIRE) -- Patent can remove any fixed frequency interfering with original signal of interest preserving critical intracardiac dataBioSig now has 56 worldwide...